Literature DB >> 2058426

Cloverleaf skull--a severe form of Crouzon's syndrome: a new concept in aetiology.

M Rohatgi1.   

Abstract

This is a study of 6 patients of cloverleaf skull (CLS) who were treated between 1980 and 1988. All of them had mild to severe degree of craniofacial dysostosis of Crouzon type with variable degrees of exorbitism (pseudoexophthalmus), raised intracranial pressure and mental retardation. All except one patient had maternal H O fever and/or drug intake during the first trimester or toxaemia of pregnancy. The skull X-ray showed typical CLS with expanded middle cranial fossa, foreshortened anterior and posterior fossae and honey-comb appearance in the occiput. Preoperative CT scan revealed generalized hydrocephalus in older patients but only cystic dilatation of the temporal horns in younger infants. The best treatment results were observed in the youngest infant, 7 weeks old, following morcellation cranioplasty, duroplasty, orbital decompression and delayed V.P. Shunt. Fronto-orbital advancement procedure gave satisfactory results in older infants except in those with severe craniofacial stenosis. A delayed CSF shunt is only indicated for progressive postoperative hydrocephalus. Immediate survival was 100% and late 50%. The deaths were due to complications of hydrocephalus. Survival was better in those having less severe Crouzon Syndrome irrespective of the type of surgical treatment. However, timely CSF shunt surgery played an important role in the long term survival, improvement of I.Q., and ultimate shape of head. The study suggests that CLS is a severe malformation of Crouzons disease due to teratogenic damage in the first trimester of pregnancy causing developmental aberration of primary mesenchyme of the neurocranial capsule and base of the skull. The cystic dilatation of the temporal horns is the earliest sign of hydrocephalus and occurs secondary to disturbed growth of the cerebral capsule.

Entities:  

Mesh:

Year:  1991        PMID: 2058426     DOI: 10.1007/bf01407666

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  18 in total

1.  [Cloverleaf skull syndrome].

Authors:  S Saji; A Misao; T Hirose; T Funakoshi; H Yamada
Journal:  No To Shinkei       Date:  1977-04

2.  Subtotal neonatal calvariectomy for severe craniosynostosis.

Authors:  J W Hanson; M P Sayers; L M Knopp; C Macdonald; D W Smith
Journal:  J Pediatr       Date:  1977-08       Impact factor: 4.406

3.  Recent advances in medical imaging: surgery planning and simulation.

Authors:  C N McEwan; K Fukuta
Journal:  World J Surg       Date:  1989 Jul-Aug       Impact factor: 3.352

4.  Temporal bone findings in cloverleaf skull syndrome.

Authors:  H Miyata; Y Kato; M Yoshimura; S Saji
Journal:  Acta Otolaryngol Suppl       Date:  1988

5.  Cloverleaf skull: Kleeblattschädel-deformity syndrome.

Authors:  C R Angle; M S McIntire; R C Moore
Journal:  Am J Dis Child       Date:  1967-08

6.  The management of the Kleeblattschadel syndrome.

Authors:  G L Rogers; W Penland; M P Sayers; E Kosnik
Journal:  Ann Ophthalmol       Date:  1981-10

7.  In utero diagnosis of Kleeblattschädel (cloverleaf skull).

Authors:  A F Salvo
Journal:  Prenat Diagn       Date:  1981-04       Impact factor: 3.050

8.  Clinical conference I. Calvarium and cranial base in Apert's syndrome: an autopsy report.

Authors:  S Kreiborg; U Prydsoe; E Dahl; P Fogh-Anderson
Journal:  Cleft Palate J       Date:  1976-07

9.  Generous craniectomy for Kleeblattschädel anomaly.

Authors:  P T Turner; A F Reynolds
Journal:  Neurosurgery       Date:  1980-05       Impact factor: 4.654

10.  Cloverleaf skull syndrome. An autopsy case and review of literature.

Authors:  J Sano; Y Sasaki; H Shimada; K Misugi; H Kagyo
Journal:  Acta Pathol Jpn       Date:  1982-09
View more
  1 in total

1.  About the operative management and post-operative neural development of patients with cloverleaf skull deformity.

Authors:  Matthias Preuss; Marco Stein; Bernd A Neubauer; Heidrun Schaaf; Hans-Peter Howaldt; Ulf Nestler; Petros Christophis
Journal:  Childs Nerv Syst       Date:  2010-03-26       Impact factor: 1.475

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.